Please assess the completion status of the following clinical trial:

Trial Title: Femtosecond Laser for Cataract Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Able and willing to comply with the treatment/follow-up schedule and requirements~* Able to understand and provide written Informed Consent~* ETDRS visual acuity equal to or worse than 20/32 (best corrected)~* Age between 50 and 80 years old~* Pupil dilates to at least 6 mm~* Subject able to fixate~* Grade 1-4 nuclear sclerotic cataract (LOCS III)~* Axial length between 22 and 26 mm~Exclusion Criteria:~* Pregnant, intending to become pregnant during course of the study, less than 3 months postpartum or less than 6 weeks after completion of breastfeeding~* Participation in a study of another device or drug within 3 months prior to study enrollment or during this study, and as per the Investigator's careful discretion, as long as not contradictory to any of the above criteria~* Any condition which, in the Investigator's opinion, would make it unsafe (for the subject or for the study personnel) to treat the subject as part of this research study or for which cataract surgery is contraindicated~* Anterior chamber depth (anterior corneal surface to anterior capsule margin) less than 2.5 mm via IOL Master (Zeiss).~* History of prior ocular surgery~* History of ocular trauma~* Co-existing ocular disease affecting vision~* History or current use of alpha-1 antagonist medication (e.g., Flomax)~* Known sensitivity to planned concomitant medications

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- U/S Surgery and CCC (Type: ACTIVE_COMPARATOR): Ultrasound (U/S) cataract surgery and continuous curvilinear capsulorhexis (CCC).
- FS Laser Surgery (Type: EXPERIMENTAL): For femtosecond laser-assisted cataract surgery (FS Laser Surgery), subjects will receive capsulotomy, lens segmentation and, at investigator discretion, lens softening using the femtosecond laser device.

Based on this trial design, predict the completion outcome and termination type (if applicable).